Whitehawk Therapeutics (WHWK) Divestments (2025)
Whitehawk Therapeutics (WHWK) reported Divestments of -$70000.0 for Q3 2025, down 100.07% on a QoQ basis from $101.4 million in Q1 2025.
Whitehawk Therapeutics (WHWK) has 1 years of Divestments data on file, last reported at -$70000.0 in Q3 2025.
- Quarterly Divestments changed N/A year-over-year to -$70000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$70000.0 (down 100.07% YoY) and the FY2025 annual result came in at $101.3 million, changed N/A from the prior year.
- Divestments declined to -$70000.0 in Q3 2025 per WHWK's latest filing, from $101.4 million in the prior quarter.
- Across five years, Divestments topped out at $101.4 million in Q1 2025 and bottomed at -$70000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -70,000.00 |
| Mar 31, 2025 | 101.36 Mn |